Austrian Syndrome
Austrian syndrome (also called Osler's triad) is the simultaneous occurrence of three serious infections caused by Streptococcus pneumoniae:
- Pneumonia
- Infective endocarditis
- Meningitis
History
- First described clinically by Sir William Osler in 1881
- Formally published by Robert Austrian in 1957, who reported 8 cases involving pneumococcal endocarditis, meningitis, and aortic valve rupture — hence the eponym
Pathophysiology
The triad results from hematogenous dissemination of S. pneumoniae. Pneumonia is typically the initial infection. Bacteremia then seeds the heart valves (endocarditis) and meninges (meningitis), resulting in simultaneous multi-organ involvement.
Epidemiology & Risk Factors
| Factor | Detail |
|---|
| Sex | Male predominance (M:F ratio ~2.4:1) |
| Mean age | ~56.5 years |
| Alcoholism | Present in ~41% of cases — the single strongest risk factor |
| Others | Diabetes mellitus, chronic kidney disease, liver disease, pulmonary disease, asplenism, immunosuppression, IV drug use |
The introduction of beta-lactam antibiotics (1940s) and the pneumococcal vaccine (1977) dramatically reduced incidence from 10–15% to ~3% in the population.
Clinical Presentation
Patients present with symptoms spanning multiple organ systems:
- Fever (65%), often high (mean admission temp ~38.9°C)
- Altered mental status / confusion (69%) — the most common symptom
- Shortness of breath, productive cough, chest pain (pneumonia)
- Cardiac murmur (endocarditis — may be absent early)
- Signs of meningismus (neck stiffness, photophobia)
Mean symptom duration before hospital presentation: ~8 days
Cardiac Involvement
- Aortic valve is most commonly affected (~56–75% of cases)
- Mitral valve involvement is less common but reported
- Complications include valve perforation, aortic root fistula, pericarditis with tamponade, and valvular regurgitation
Diagnosis
Requires a high index of clinical suspicion. Workup includes:
- Blood cultures — typically grow S. pneumoniae
- CSF analysis (lumbar puncture) — elevated WBC, low glucose, elevated protein, positive Gram stain/culture
- Chest X-ray / CT chest — lobar or multifocal pneumonia
- Echocardiography (TTE/TEE) — vegetations on cardiac valves
- Urine pneumococcal antigen
Management
Requires multidisciplinary care (infectious disease, cardiology, cardiac surgery, neurology, pulmonology):
| Component | Details |
|---|
| Antibiotics | Third-generation cephalosporin (e.g., ceftriaxone) as backbone. Add vancomycin if meningitis is suspected or beta-lactam resistance is a concern. Two agents with different anti-pneumococcal mechanisms preferred. Mean duration: ~5.6 weeks |
| Surgical valve replacement | Required in ~56% of cases, usually for aortic valve. Surgery appears associated with better outcomes |
| ICU admission | ~70% of patients require ICU care |
| Monitoring | Serial echos, neurological monitoring, supportive organ care |
Prognosis
- Mortality: ~28–30% even with appropriate antibiotics and surgery
- Mortality can reach 60% without early diagnosis and treatment
- Average hospital stay: ~36.9 days
- Poor outcome drivers: delayed presentation, aortic valve destruction, septic emboli, concurrent meningitis
Key Pearl
Any patient with pneumococcal pneumonia + bacteremia who has risk factors (especially alcoholism, older age, male sex, immunosuppression) should prompt immediate cardiac evaluation with echocardiography and LP to rule out the full triad — even in the absence of classic endocarditis or meningitis signs, as these may lag in presentation.
Sources: Madu et al., Clin Med (Lond) 2024 — Systematic Review of 71 cases [PMID: 38649138]; PMC7473259; PMC9805360